• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.

作者信息

Bujia J, Holly A, Sudhoff H, Antoli-Candela F, Tapia M G, Kastenbauer E

机构信息

Department of Otorhinolaryngology, Ludwig Maximilians University of Munich, Germany.

出版信息

ORL J Otorhinolaryngol Relat Spec. 1996 Jan-Feb;58(1):23-6. doi: 10.1159/000276789.

DOI:10.1159/000276789
PMID:8718533
Abstract

Cholesteatoma epithelium is characterized by a keratinocyte dysregulation with aggressive growth subsequently destroying the middle ear mucosa. The monoclonal antibody Ki-67 recognizes a nuclear antigen expressed by cells in the G1, S, and G2/M phases being used to determine the growing cell fraction in tissue samples. Cryostat sections of skin and cholesteatoma biopsies were examined immunohistochemically for reactivity with Ki-67 using the alkaline phosphatase-anti-alkaline phosphatase method. Nuclear staining was seen in a small number of keratinocytes located in the basal cell layer of normal auditory meatal skin. In contrast, numerous cells of the basal and suprabasal layers in cholesteatoma were found to react with Ki-67. A cytoplasmic staining was also observed in both skin and cholesteatoma. In cholesteatoma, the cytoplasmic staining was stronger. These results clearly show that cholesteatoma epithelium proliferates at a higher rate than normal epidermis, confirming the hyperproliferative behavior of cholesteatoma.

摘要

相似文献

1
Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
ORL J Otorhinolaryngol Relat Spec. 1996 Jan-Feb;58(1):23-6. doi: 10.1159/000276789.
2
Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.中耳胆脂瘤中c-myc癌基因产物的免疫组织化学显示
Eur Arch Otorhinolaryngol. 1995;252(6):366-9. doi: 10.1007/BF00178279.
3
Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
Laryngoscope. 1995 Nov;105(11):1227-31. doi: 10.1288/00005537-199511000-00017.
4
Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.中耳胆脂瘤中增殖细胞核抗原的免疫组织化学检测
Eur Arch Otorhinolaryngol. 1996;253(1-2):21-4. doi: 10.1007/BF00176697.
5
Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1.儿童胆脂瘤的免疫生物学特性:通过MIB1对上皮增殖进行定量分析。
Laryngoscope. 1996 Jul;106(7):865-8. doi: 10.1097/00005537-199607000-00015.
6
[Immunohistochemical detection of c-myc proto-oncogene products in middle ear cholesteatoma].中耳胆脂瘤中c-myc原癌基因产物的免疫组织化学检测
Laryngorhinootologie. 1995 Jun;74(6):348-51. doi: 10.1055/s-2007-997755.
7
[Expression of calgranulin A and B in middle ear cholesteatoma].
Laryngorhinootologie. 1995 Jan;74(1):33-5. doi: 10.1055/s-2007-997682.
8
p53 Expression and keratinocyte hyperproliferation in middle ear cholesteatoma.
Clin Otolaryngol Allied Sci. 2002 Dec;27(6):505-8. doi: 10.1046/j.1365-2273.2002.00622.x.
9
[Comparative analysis of the proliferative capacity of cholesteatomas].[胆脂瘤增殖能力的比较分析]
Acta Otorrinolaringol Esp. 2000 May;51(4):299-307.
10
[Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].[中耳胆脂瘤上皮过度增殖的免疫组织化学研究]
Zhonghua Er Bi Yan Hou Ke Za Zhi. 2002 Apr;37(2):118-20.

引用本文的文献

1
Osteopontin-driven partial epithelial-mesenchymal transition governs the development of middle ear cholesteatoma.骨桥蛋白驱动的部分上皮-间充质转化控制中耳胆脂瘤的发生。
Cell Cycle. 2024 Mar;23(5):537-554. doi: 10.1080/15384101.2024.2345481. Epub 2024 Apr 25.
2
Proto-oncogene mutations in middle ear cholesteatoma contribute to its pathogenesis.中耳胆脂瘤中的原癌基因突变导致其发病机制。
BMC Med Genomics. 2023 Nov 15;16(1):288. doi: 10.1186/s12920-023-01640-6.
3
Comparison of changes in mitochondrial bioenergetics between keratinocytes in human external auditory canal skin and cholesteatomas from normoxia to hypoxia.
比较正常人外耳道皮肤角质细胞和胆脂瘤在常氧到低氧环境下线粒体生物能量学的变化。
Sci Rep. 2018 Jan 9;8(1):125. doi: 10.1038/s41598-017-18536-y.
4
Large-scale proteomics differentiates cholesteatoma from surrounding tissues and identifies novel proteins related to the pathogenesis.大规模蛋白质组学可区分胆脂瘤与周围组织,并鉴定出与发病机制相关的新蛋白质。
PLoS One. 2014 Aug 5;9(8):e104103. doi: 10.1371/journal.pone.0104103. eCollection 2014.
5
Comparative analysis of the expression of involucrin, filaggrin and cytokeratin 4, 10, 16 in cholesteatoma.胆脂瘤中兜甲蛋白、丝聚合蛋白及细胞角蛋白4、10、16表达的比较分析
Korean J Audiol. 2012 Dec;16(3):124-9. doi: 10.7874/kja.2012.16.3.124. Epub 2012 Dec 18.
6
Myeloperoxydase activity in the pathogenesis of cholesteatoma.髓过氧化物酶活性在胆脂瘤发病机制中的作用
Indian J Otolaryngol Head Neck Surg. 2010 Jan;62(1):32-5. doi: 10.1007/s12070-010-0011-y. Epub 2010 Jun 4.
7
Etiopathogenesis of cholesteatoma.胆脂瘤的病因发病机制。
Eur Arch Otorhinolaryngol. 2004 Jan;261(1):6-24. doi: 10.1007/s00405-003-0623-x. Epub 2003 Jun 27.
8
Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.中耳胆脂瘤中增殖细胞核抗原的免疫组织化学检测
Eur Arch Otorhinolaryngol. 1996;253(1-2):21-4. doi: 10.1007/BF00176697.